Building trust in real-world evidence and comparative effectiveness research: the need for transparency

Guidelines for good pharmacoepidemiology practice (GPP)

(2015)   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A global overview of renal registries: a systematic review

(2015) Frank Xiaoqing Liu et al.   BMC Nephrology

Identifying real-world data for observational studies: A systematic approach

(2014) K.E. Smoyer-Tomic et al.   VALUE IN HEALTH

Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden

(2014) Ken O’Day et al.   JOURNAL OF MEDICAL ECONOMICS

Prospective Observational Studies to Assess Comparative Effectiveness: The ISPOR Good Research Practices Task Force Report

(2012) Marc L. Berger et al.   VALUE IN HEALTH

Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing–remitting multiple sclerosis in Sweden

(2012) Niklas Bergvall et al.   JOURNAL OF MEDICAL ECONOMICS

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

(2008) Erik von Elm et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY